Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

ADPT Adaptive Biotechnologies

7.120
+0.270+3.94%
Close 09/30 16:00 ET
7.1200.0000.00%
Post Mkt Price 09/30 16:02 ET
High
7.430
Open
6.920
Turnover
7.05M
Low
6.840
Pre Close
6.850
Volume
975.69K
Market Cap
1.02B
P/E(TTM)
Loss
52wk High
37.550
Shares
142.87M
P/E(Static)
Loss
52wk Low
5.955
Float Cap
697.99M
Bid/Ask %
0.00%
Historical High
71.250
Shs Float
98.03M
Volume Ratio
0.99
Historical Low
5.955
Dividend TTM
--
Div Yield TTM
--
P/B
1.96
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
1.00%
Amplitude
8.61%
Avg Price
7.221
Lot Size
1
Float Cap
697.99M
Bid/Ask %
0.00%
Historical High
71.250
Shs Float
98.03M
Volume Ratio
0.99
Historical Low
5.955
Dividend TTM
--
P/B
1.96
Dividend LFY
--
Turnover Ratio
1.00%
Amplitude
8.61%
Avg Price
7.221
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. It harnesses the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines. The company was founded by Chad Robins, Harlan Robins, and Chris Carlson in September 2009 and is headquartered in Seattle, WA.
CEO: Mr. Chad Robins
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...